country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

製品番号: HY-N21963

Copy Link Print Information

Sutherlandioside B

Sutherlandioside B is an antioxidant. Sutherlandioside B reduces the production of reactive oxygen species (ROS). Sutherlandioside B exhibits antiviral activity. Sutherlandioside B can be used in studies related to viral infections.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号: 1055329-47-9
分子式: C₃₆H₆₀O₁₀
分子量:652.86

保管条件:

Please store the product under the recommended conditions in the Certificate of Analysis.

Sutherlandioside B 構造式

CAS 番号: 1055329-47-9

価格（税別）

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性

製品説明

体外実験

Sutherlandioside B shows in vitro antiviral activity against Epstein-Barr virus and Tacaribe virus^[2].
Sutherlandioside B (6.25-25 μg/mL; 60 min pretreatment, 18 h co-stimulation) modestly reduces LPS/IFNγ-induced ROS production in RAW 264.7 cells at a concentration of 6.25 μg/mL, with reduced activity at higher concentrations^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

化学情報

CAS 番号 1055329-47-9
分子量 652.86
分子式 C₃₆H₆₀O₁₀
SMILES

O=C1[C@]23[C@@]4(C3)[C@]([C@H](C[C@@]2([H])C(C)([C@@H](C1)O)C)O)([H])[C@]5([C@](CC4)([C@@](CC5)([H])[C@H](C)CC[C@H](O)C(C)(C)O[C@@H]6O[C@@H]([C@H]([C@@H]([C@H]6O)O)O)CO)C)C
Structure Classification
- Saccharides
- Monosaccharides
Initial Source
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション

取扱説明書 (2659 KB)

参考文献

[1]. Brownstein KJ, et al. Isolation of Sutherlandioside B from Sutherlandia frutescens by Spiral Countercurrent Chromatography. J Liq Chromatogr Relat Technol. 2015;38(4):423-429.

[2]. Fu X. Phytochemical studies on the medicinal plant Sutherlandia frutescens [dissertation]. University (MS): University of Mississippi; 2012 Jan.

[3]. Lei W, et al. Unveiling the anti-inflammatory activity of Sutherlandia frutescens using murine macrophages. International immunopharmacology. 2015 Dec;29(2):254-262.

[4]. Chen L, et al. Comparative cardio and developmental toxicity induced by the popular medicinal extract of Sutherlandia frutescens (L.) R.Br. detected using a zebrafish Tuebingen embryo model. BMC complementary and alternative medicine. 2018 Oct 05;18(1):273.

[5]. Avula B, et al. Quantitative determination of flavonoids and cycloartanol glycosides from aerial parts of Sutherlandia frutescens (L.) R. BR. by using LC-UV/ELSD methods and confirmation by using LC-MS method. J Pharm Biomed Anal. 2010 Jun 5;52(2):173-80.

Calculators

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

お問い合わせ在庫あり

Other size

お問い合わせ